Bangladesh, July 26 -- Government's revenue authority has moved to scrutinise production data of pharmaceuticals under an effort to crosscheck actual outputs with value-ddedef tax (VAT) returns submitted by the companies and strengthen revenue compliance.

Advertisement The Large Taxpayers Unit (LTU) under the VAT wing of the National Board of Revenue (NBR) has written to the Directorate General of Drug Administration (DGDA) for furnishing detailed production information of pharmaceutical products to verify whether VAT declarations are consistent with actual manufacturing output.

Under the drive, meant for a larger end of enhancing government revenues to finance what is dubbed an ambitious national budget, the LTU has sought last five y...